Andrea R Mospan

8PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsCardiology (incl. cardiovascular diseases)Medical molecular engineering of nucleic acids and proteinsMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 02, 2026
Impact of Alkaline Phosphatase Normalization on Complication-Free Survival in Primary Biliary Cholangitis.

Anish Reddy, Adrielly Martins, Christopher L Bowlus

|Jul 16, 2025
The Magnitude of Polypharmacy and Role of Disease Severity and Patient Sex in Medication Use Among Patients With MASLD Enrolled in TARGET-NASH.

Brent A Neuschwander-Tetri, Heather L Morris, Andrea R Mospan

|Jun 11, 2025
Cardiovascular Risk Assessment Tools are Insufficient for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

A Sidney Barritt, Elliot B Tapper, Philip N Newsome

|Dec 15, 2021
Editorial: targeting liver biopsy in NAFLD-the need to expand our non-invasive tools. Authors' reply.

Hannah P Kim, Andrea R Mospan, Michael W Fried

|Oct 25, 2021
Liver biopsy in the real world-reporting, expert concordance and correlation with a pragmatic clinical diagnosis.

Hannah P Kim, Michael O Idowu, Andrea R Mospan

Pageof 2